Reconstructive surgery for mycetoma: a case series

  • Mohamed AbdelrahmanEmail author
  • Irfan Jumabhoy
  • Eltaib A. Saad
  • Gamal M. Abdulla
Original Paper



Mycetoma is an under recognised but significant disease endemic in various countries and associated with high morbidity. Treatment is a combination of antimicrobial therapy, with surgery often reserved for refractory or delayed cases where functional sequelae are often ignored. This case series aimed to provide preliminary evidence for the role of reconstructive surgery in treating mycetoma.


Twenty-six cases of eumycetoma suitable for reconstruction post-excision were identified between 2013 and 2016 in three centres in Sudan. The choice of reconstruction was based on consensus of the treating team, and relevant end-points noted including patient satisfaction, mobility and complication rate.


Mycetoma lesions affected primarily the limbs (n = 23), with three cases involving the gluteal region. A range of reconstructive options was used including skin grafting (n = 14), local flaps (n = 5) and regional flaps (n = 4). Three cases were closed primarily. No complications were noted, and disease recurrence was not found in any of the patients. Subjective interviewing revealed adequate patient satisfaction with cosmesis, and all patients reached a post-operative mobility status at least equivalent to their pre-morbid state.


This study demonstrates the feasibility of reconstructive surgery in selective patients with mycetoma as part of their treatment protocol.

Level of Evidence: Level IV, therapeutic study.


Mycetoma Reconstruction Tropical surgery Neglected disease 


Compliance with ethical standards

Conflict of interest

Mohamed Abdelrahman, Irfan Jumabhoy, Eltaib A. Saad and Gamal M. Abdulla declare that they have no conflicts of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.


  1. 1.
    Fahal AH, Hassan MA (1992) Mycetoma. Br J Surg 79(11):1138–1141CrossRefGoogle Scholar
  2. 2.
    Zijlstra EE, van de Sande WWJ, Welsh O, Mahgoub ES, Goodfellow M, Fahal AH (2016) Mycetoma: a unique neglected tropical disease. Lancet Infect Dis 16(1):100–112CrossRefGoogle Scholar
  3. 3.
    Bonifaz A, Tirado-Sanchez A, Calderon L, Saul A, Araiza J, Hernandez M et al (2014) Mycetoma: experience of 482 cases in a single center in Mexico. PLoS Negl Trop Dis 8(8):e3102CrossRefGoogle Scholar
  4. 4.
    Fahal AH (2004) Mycetoma: a thorn in the flesh. Trans R Soc Trop Med Hyg 98(1):3–11CrossRefGoogle Scholar
  5. 5.
    Hay RJ, Fahal AH (2015) Mycetoma: an old and still neglected tropical disease. Trans R Soc Trop Med Hyg 109(3):169–170CrossRefGoogle Scholar
  6. 6.
    van de Sande WW (2013) Global burden of human mycetoma: a systematic review and meta-analysis. PLoS Negl Trop Dis 7(11):e2550CrossRefGoogle Scholar
  7. 7.
    Welsh O, Vera-Cabrera L, Salinas-Carmona MC (2007) Mycetoma. Clin Dermatol 25(2):195–202CrossRefGoogle Scholar
  8. 8.
    Fahal A, Mahgoub el S, El Hassan AM, Abdel-Rahman ME (2015) Mycetoma in the Sudan: an update from the Mycetoma Research Centre, University of Khartoum, Sudan. PLoS Negl Trop Dis 9(3):e0003679CrossRefGoogle Scholar
  9. 9.
    Suleiman SH, Wadaella el S, Fahal AH (2016) The surgical treatment of mycetoma. PLoS Negl Trop Dis 10(6):e0004690CrossRefGoogle Scholar
  10. 10.
    Welsh O, Al-Abdely HM, Salinas-Carmona MC, Fahal AH (2014) Mycetoma medical therapy. PLoS Negl Trop Dis 8(10):e3218CrossRefGoogle Scholar
  11. 11.
    Fahal A, Mahgoub el S, El Hassan AM, Jacoub AO, Hassan D (2015) Head and neck mycetoma: the Mycetoma Research Centre experience. PLoS Negl Trop Dis 9(3):e0003587CrossRefGoogle Scholar
  12. 12.
    Alam K, Maheshwari V, Bhargava S, Jain A, Fatima U, Haq EU (2009) Histological diagnosis of madura foot (mycetoma): a must for definitive treatment. J Global Infect Dis 1(1):64–67CrossRefGoogle Scholar
  13. 13.
    Tamir G, Adler A, Hagler J, Hauben DJ, Goldberg I (1995) Mycetoma of the foot - surgical treatment with free flap reconstruction. Eur J Plast Surg 18:124–126Google Scholar
  14. 14.
    Mestre T, Vieira R, Coutinho J (2015) Mycetoma of the foot--diagnosis of the etiologic agent and surgical treatment. Am J Trop Med Hyg 93(1):1–2CrossRefGoogle Scholar
  15. 15.
    Gismalla MDA, Abdulla GM, Ali MM, Mohamed SM (2016) Wide surgical excision and reconstruction of eumycetoma in Gezira Mycetoma Centre. Glob J Med 16(2):14–17Google Scholar
  16. 16.
    Maina AM, Macharia JT (2012) Alleviating a Nomad's anguish: successful treatment of a case of leg mycetoma-a case report. Case Rep Orthop 2012:753174PubMedPubMedCentralGoogle Scholar
  17. 17.
    Ali A, Khadda S, Yadav AK, Parmar A, Sakhrani JK, Kapoor A (2015) Giant eumycetoma gluteal region: excision and V-Y flap advancement. Int J Sci Rep 1(2):146–147CrossRefGoogle Scholar
  18. 18.
    Wadal A, Elhassan TA, Zein HA, Abdel-Rahman ME, Fahal AH (2016) Predictors of post-operative mycetoma recurrence using machine-learning algorithms: the Mycetoma Research Center experience. PLoS Negl Trop Dis 10(10):e0005007CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  • Mohamed Abdelrahman
    • 1
    • 2
    Email author
  • Irfan Jumabhoy
    • 2
  • Eltaib A. Saad
    • 1
  • Gamal M. Abdulla
    • 3
  1. 1.Department of Surgery, Faculty of MedicineUniversity of KhartoumKhartoumSudan
  2. 2.Department of Plastic SurgeryNottingham City HospitalNottinghamUK
  3. 3.Department of Surgery, Faculty of MedicineUniversity of GeziraWad MadaniSudan

Personalised recommendations